Haleon CEO Sees Supplements as Key to Weight-Loss Market Amid Prescription Medicine Rise

Haleon's CEO believes that supplements for GLP-1 drugs are the company's best bet for entering the weight-loss market, despite the popularity of prescription obesity medicines pushing over-the-counter diet pills to the sidelines. Haleon is home to brands like PainRelief brand Advil, and its consumer healthcare group is looking for new ways to enter the weight-loss market.